Scholarlink

Background <p>S100A7 expression is increased in oral potentially malignant disorders (OPMD) at risk of transformation to oral squamous cell carcinoma (OSCC). The objective of this study was to evaluate S100A7 expression in OPMD which transformed and to correlate these results with the 3-tier and 2-tier dysplasia grading systems, and an S100A7 immunohistochemistry-based signature algorithm (S100A7 ARS).</p> Methods <p>Formalin fixed paraffin embedded specimens from 48 patients with OPMD that had transformed into OSCC were selected. Thirty-five patients with multiple biopsies of dysplasia which had not transformed, and 25 cases with normal appearing and/or hyperkeratotic oral mucosa were included as control groups. Specimens were stained for S100A7 protein by immunohistochemical methods. Expression of S100A7 was assessed semi-quantitatively and by image analysis for the S100A7 ARS.</p> Results <p>The semi-quantitative score had strong correlation with the S100A7 ARS and allowed differentiation of OPMD from the Control groups. The S100A7ARS was also useful in differentiation of OPMD that transformed to carcinoma from non-transforming cases (p &lt; 0.05).</p> Conclusion <p>S100A7 immunohistochemical staining and the S100A7 ARS has potential for identifying oral potentially malignant lesions that have an increased risk of malignant transformation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

S100A7 as a predictive biomarker in malignant transformation of oral epithelial dysplastic lesions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月25日

查看全文
  • Jeffrey Soparlo,
  • Lachlan McLean,
  • Christina McCord,
  • Linda Jackson-Boeters,
  • Michael Shimizu,
  • Michael Robinson,
  • Wanninayake M. Tilakaratne,
  • Mark R. Darling

摘要

Background

S100A7 expression is increased in oral potentially malignant disorders (OPMD) at risk of transformation to oral squamous cell carcinoma (OSCC). The objective of this study was to evaluate S100A7 expression in OPMD which transformed and to correlate these results with the 3-tier and 2-tier dysplasia grading systems, and an S100A7 immunohistochemistry-based signature algorithm (S100A7 ARS).

Methods

Formalin fixed paraffin embedded specimens from 48 patients with OPMD that had transformed into OSCC were selected. Thirty-five patients with multiple biopsies of dysplasia which had not transformed, and 25 cases with normal appearing and/or hyperkeratotic oral mucosa were included as control groups. Specimens were stained for S100A7 protein by immunohistochemical methods. Expression of S100A7 was assessed semi-quantitatively and by image analysis for the S100A7 ARS.

Results

The semi-quantitative score had strong correlation with the S100A7 ARS and allowed differentiation of OPMD from the Control groups. The S100A7ARS was also useful in differentiation of OPMD that transformed to carcinoma from non-transforming cases (p < 0.05).

Conclusion

S100A7 immunohistochemical staining and the S100A7 ARS has potential for identifying oral potentially malignant lesions that have an increased risk of malignant transformation.